Covid-19 and cardiovascular disease

BMJ (Clinical Research Ed.)
|May 22, 2020
PubMed

Insights

This guideline addresses cardiovascular disease diagnosis and management during the COVID-19 pandemic. It provides recommendations for healthcare professionals to ensure optimal patient care amidst the global health crisis.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic presents unique challenges for managing patients with cardiovascular disease.
  • Healthcare systems worldwide have been strained, impacting routine and emergency cardiovascular care.
  • Emerging evidence necessitated updated guidance for clinicians.

Purpose of the Study:

  • To provide evidence-based recommendations for the diagnosis and management of cardiovascular disease in the context of the COVID-19 pandemic.
  • To guide clinical decision-making for healthcare professionals caring for cardiovascular patients during the pandemic.
  • To offer strategies for adapting cardiovascular services to the evolving pandemic landscape.

Main Methods:

  • The guideline was developed by the European Society of Cardiology (ESC) expert task force.
  • It involved a comprehensive review of available scientific literature and expert consensus.
  • Recommendations were formulated based on the best available evidence and clinical experience.

Main Results:

  • The guideline details strategies for risk stratification of cardiovascular patients regarding COVID-19 infection.
  • It outlines modifications in the management of acute coronary syndromes, heart failure, arrhythmias, and other cardiovascular conditions.
  • Recommendations cover the use of personal protective equipment, telemedicine, and resource allocation.

Conclusions:

  • Adherence to updated guidelines is crucial for maintaining high-quality cardiovascular care during the COVID-19 pandemic.
  • Proactive adaptation of clinical practice and healthcare services is essential to mitigate the impact of the pandemic on cardiovascular patients.
  • Continuous evaluation of emerging data will be necessary to refine management strategies.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
270
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
778
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
278
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.9K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.7K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
239